StockMacro
Company, fund or insider

Help

Menu

Vericel

$57.52 +64% in 6 monthsMarket cap $2.9B

VCEL on XNAS, Health Care, Vericel Corporation, job postings

Measures activity, not value. Not investment advice.

Shares up 40% in a month and 52% in a year as profit rose 155% to $33.3M.

  • GoodFederal contracts and grants $35.4M over 12 months, up from $402K
  • GoodLatest quarter revenue rose 26% to $85.4M

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Industry
Biological products, (no diagnostic substances) (Health Care)
Employees
398
Website
vcel.com
Listed
Nasdaq, US
Last results
5 Nov 2026
Next results
expected around 12 Jan 2027 (an estimate: a year ago it reported on 13 Jan 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $85.4M, net income $14.2M.
Quarter to 31 Dec 2021: revenue $47.6M, net income $4.5MQuarter to 31 Dec 2021: revenue $47.6M, net income $4.5MQuarter to 31 Mar 2022: revenue $36.1M, net income -$7.1MQuarter to 31 Mar 2022: revenue $36.1M, net income -$7.1MQuarter to 30 Jun 2022: revenue $37.0M, net income -$9.0MQuarter to 30 Jun 2022: revenue $37.0M, net income -$9.0MQuarter to 30 Sep 2022: revenue $38.6M, net income -$6.6MQuarter to 30 Sep 2022: revenue $38.6M, net income -$6.6MQuarter to 31 Dec 2022: revenue $52.7M, net income $5.9MQuarter to 31 Dec 2022: revenue $52.7M, net income $5.9MQuarter to 31 Mar 2023: revenue $41.0M, net income -$7.5MQuarter to 31 Mar 2023: revenue $41.0M, net income -$7.5MQuarter to 30 Jun 2023: revenue $45.9M, net income -$5.0MQuarter to 30 Jun 2023: revenue $45.9M, net income -$5.0MQuarter to 30 Sep 2023: revenue $45.6M, net income -$3.7MQuarter to 30 Sep 2023: revenue $45.6M, net income -$3.7MQuarter to 31 Dec 2023: revenue $65.0M, net income $13.0MQuarter to 31 Dec 2023: revenue $65.0M, net income $13.0MQuarter to 31 Mar 2024: revenue $51.3M, net income -$3.9MQuarter to 31 Mar 2024: revenue $51.3M, net income -$3.9MQuarter to 30 Jun 2024: revenue $52.7M, net income -$4.7MQuarter to 30 Jun 2024: revenue $52.7M, net income -$4.7MQuarter to 30 Sep 2024: revenue $57.9M, net income -$901KQuarter to 30 Sep 2024: revenue $57.9M, net income -$901KQuarter to 31 Dec 2024: revenue $75.4M, net income $19.8MQuarter to 31 Dec 2024: revenue $75.4M, net income $19.8MQuarter to 31 Mar 2025: revenue $52.6M, net income -$11.2MQuarter to 31 Mar 2025: revenue $52.6M, net income -$11.2MQuarter to 30 Jun 2025: revenue $63.2M, net income -$553KQuarter to 30 Jun 2025: revenue $63.2M, net income -$553KQuarter to 30 Sep 2025: revenue $67.5M, net income $5.1MQuarter to 30 Sep 2025: revenue $67.5M, net income $5.1MQuarter to 31 Dec 2025: revenue $92.9M, net income $23.2MQuarter to 31 Dec 2025: revenue $92.9M, net income $23.2MQuarter to 31 Mar 2026: revenue $68.4M, net income -$6.3MQuarter to 31 Mar 2026: revenue $68.4M, net income -$6.3MQuarter to 30 Jun 2026: revenue $77.5M, net income $2.2MQuarter to 30 Jun 2026: revenue $77.5M, net income $2.2MQuarter to 30 Sep 2026: revenue $85.4M, net income $14.2MQuarter to 30 Sep 2026: revenue $85.4M, net income $14.2M
31 Dec 2021RevenueNet incomeNet losstallest bar $92.9M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$85.4M$14.2M
30 Jun 2026$77.5M$2.2M
31 Mar 2026$68.4M-$6.3M
31 Dec 2025$92.9M$23.2M
30 Sep 2025$67.5M$5.1M
30 Jun 2025$63.2M-$553K
31 Mar 2025$52.6M-$11.2M
31 Dec 2024$75.4M$19.8M
30 Sep 2024$57.9M-$901K
30 Jun 2024$52.7M-$4.7M
31 Mar 2024$51.3M-$3.9M
31 Dec 2023$65.0M$13.0M
30 Sep 2023$45.6M-$3.7M
30 Jun 2023$45.9M-$5.0M
31 Mar 2023$41.0M-$7.5M
31 Dec 2022$52.7M$5.9M
30 Sep 2022$38.6M-$6.6M
30 Jun 2022$37.0M-$9.0M
31 Mar 2022$36.1M-$7.1M
31 Dec 2021$47.6M$4.5M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $324.2M $258.7M
Revenue growthRevenue of the last 12 months compared with the 12 months before. +25% +8.2%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $33.3M $13.1M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $0.64 $0.25
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 74.5% 73.8% 70.4%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 8.3% 2.7% -98.6%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 10.3% 5.1% -47.8%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 9.4% -58.2%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $57.9M $20.4M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $170.3M $135.4M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. – –
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). – –
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. – 0.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $7.53
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 88.1 21.6
P/SPrice to sales: market cap divided by revenue of the last 12 months. 9.1 8.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 6.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 7.6 2.0

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
VericelVCEL (this company) $2.9B88.19.1+25%10.3%
ADMA BiologicsADMA $2.9B16.05.6+6.3%35.1%
Denali TherapeuticsDNLI $3.0Bloss–––
Iovance BiotherapeuticsIOVA $3.2Bloss8.4+51%-58.2%
Relay TherapeuticsRLAY $3.6Bloss–––
Tarsus PharmaceuticalsTARS $3.6Bloss5.3+86%-103%

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+26%

$85.4M vs $67.5M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

-22%

$2.0M vs $2.6M (quarter ended 30 Sep 2026)

Insider buy/sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$5.9M

bought $0, sold $5.9M

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+0.6%

319 13F filers vs 317

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

over 100%

56.4M shares held by 13F filers (30 Sep 2026) of 51.0M outstanding (29 Oct 2026); above 100%: the share count is probably stale

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

11%

5.4M shares sold short (30 Oct 2026) of 51.0M outstanding (29 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

9.8

5.4M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+2.4%

5.2M shares sold short in the report before, 5.4M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

57%

57% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 56%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

24

Tracked since 21 Nov 2026

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

Tracking started 21 Nov 2026; the change shows after 30 days.

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

$35.4M

the 12 months before: $402K

News Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

7

7 articles in the last 7 days; its usual week has 0 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

–

7 articles in the last 7 days; its usual week has 0: fewer than one, so there is nothing to compare with.

Price $57.52 on 20 Nov 2026, +52% over 12 months (12-month range $29.34 to $59.45)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $13.1M in the last 12 months (the 12 months before: -$11.6M).
Revenue per quarter. Revenue $85.4M in the latest quarter, +26% on a year earlier.
Capital spending per quarter. Capital spending $2.0M in the latest quarter, -22% on a year earlier.
Institutional holders (13F filers). 319 13F filers reported holding it in the latest 13F quarter, +34% on a year earlier.
Federal obligations. Federal obligations: $35.5M published in the last 12 months, +11975% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
7 May 2026Sharp changeFederal obligations jump: federal obligations jump, 35.0M vs usual 0 in the same month of earlier years (2026-04-01..2026-04-30)
7 Apr 2026Sharp changeFirst federal award: first federal award: VERICEL CORPORATION: new Department of Health and Human Services contract 75A50126C00002 ($34,880,933)
17 Feb 2026Sharp changeMany funds opening a new position: many funds opening a new position, 43 vs usual 27.50 (2025-12-31); 1.3x the same period a year earlier
2 Sep 2025Sharp changeShort interest spike: short interest spike, 5.6M vs usual 3.9M (2025-08-15); 1.8x the same period a year earlier
12 Aug 2025Sharp changeShort interest spike: short interest spike, 5.6M vs usual 3.8M (2025-07-31); 1.9x the same period a year earlier
29 Jul 2025Sharp changeShort interest spike: short interest spike, 5.3M vs usual 3.7M (2025-07-15); 2.0x the same period a year earlier
2 May 20258-K and other filingsDirector or officer change
2 May 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
6 Aug 2024Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 16.8M vs usual 3.1M (2024-06-30); 4.0x the same period a year earlier
21 May 2024Sharp changeMany funds opening a new position: many funds opening a new position, 41 vs usual 23.50 (2024-03-31); 1.1x the same period a year earlier
14 May 2024Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 14.0M vs usual 2.5M (2024-03-31); 9.9x the same period a year earlier
5 Mar 2024Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 7.8M vs usual 1.7M (2023-12-31); 7.0x the same period a year earlier
14 Nov 2023Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 6.6M vs usual 1.7M (2023-09-30); 4.7x the same period a year earlier
5 May 20238-K and other filingsDirector or officer change
5 May 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
17 May 2022Sharp changeShort interest spike: short interest spike, 8.2M vs usual 4.3M (2022-04-29); 2.4x the same period a year earlier
3 May 2022Sharp changeShort interest spike: short interest spike, 8.6M vs usual 4.3M (2022-04-14); 2.2x the same period a year earlier
29 Apr 20228-K and other filingsDirector or officer change
12 Apr 2022Sharp changeShort interest spike: short interest spike, 7.9M vs usual 4.1M (2022-03-31); 1.6x the same period a year earlier
29 Mar 2022Sharp changeShort interest spike: short interest spike, 7.9M vs usual 4.0M (2022-03-15); 2.6x the same period a year earlier
1 Mar 2022Sharp changeShort interest spike: short interest spike, 6.8M vs usual 3.9M (2022-02-15); 2.1x the same period a year earlier
24 Feb 20228-K and other filingsDirector or officer change
24 Feb 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
15 Feb 2022Sharp changeShort interest spike: short interest spike, 7.0M vs usual 3.9M (2022-01-31); 1.9x the same period a year earlier
1 Feb 2022Sharp changeShort interest spike: short interest spike, 7.0M vs usual 3.8M (2022-01-14); 2.0x the same period a year earlier
Insider net buying (open market)
Month from 1 Dec 2021: -$833K published
Month from 1 Mar 2022: -$693K published
Month from 1 May 2022: -$28K published
Month from 1 Oct 2022: -$8K published
Month from 1 Jan 2023: -$1.1M published
Month from 1 Feb 2023: -$10K published
Month from 1 Jun 2023: -$108K published
Month from 1 Jul 2023: -$39K published
Month from 1 Nov 2023: -$218K published
Month from 1 Dec 2023: -$2.5M published
Month from 1 Jan 2024: -$1.8M published
Month from 1 Feb 2024: -$1.7M published
Month from 1 Mar 2024: -$2.5M published
Month from 1 Apr 2024: -$1.6M published
Month from 1 May 2024: -$2.2M published
Month from 1 Jun 2024: -$2.2M published
Month from 1 Jul 2024: -$2.9M published
Month from 1 Aug 2024: -$1.9M published
Month from 1 Sep 2024: -$2.5M published
Month from 1 Oct 2024: -$1.9M published
Month from 1 Nov 2024: -$2.7M published
Month from 1 Dec 2024: -$740K published
Month from 1 Jan 2025: -$242K published
Month from 1 Feb 2025: -$1.1M published
Month from 1 Mar 2025: -$4.3M published
Month from 1 Apr 2025: -$2.1M published
Month from 1 May 2025: -$1.5M published
Month from 1 Jun 2025: -$401K published
Month from 1 Aug 2025: -$251K published
Month from 1 Sep 2025: -$358K published
Month from 1 Nov 2025: -$675K published
Month from 1 Dec 2025: -$254K published
Month from 1 Jan 2026: -$405K published
Month from 1 Feb 2026: -$243K published
Month from 1 Mar 2026: -$1.6M published
Month from 1 Apr 2026: -$122K published
Month from 1 May 2026: -$948K published
Month from 1 Jun 2026: -$1.2M published
Month from 1 Jul 2026: -$1.5M published
Month from 1 Aug 2026: -$1.0M published
Month from 1 Nov 2026: -$5.9M published
Revenue per quarter
Quarter ended 31 Dec 2021: $47.6M, +5.2% on a year earlier; public on 25 Feb 2022
Quarter ended 31 Mar 2022: $36.1M, +4.4% on a year earlier; public on 5 May 2022
Quarter ended 30 Jun 2022: $37.0M, -6.3% on a year earlier; public on 4 Aug 2022
Quarter ended 30 Sep 2022: $38.6M, +12% on a year earlier; public on 10 Nov 2022
Quarter ended 31 Dec 2022: $52.7M, +11% on a year earlier; public on 24 Feb 2023
Quarter ended 31 Mar 2023: $41.0M, +14% on a year earlier; public on 11 May 2023
Quarter ended 30 Jun 2023: $45.9M, +24% on a year earlier; public on 3 Aug 2023
Quarter ended 30 Sep 2023: $45.6M, +18% on a year earlier; public on 9 Nov 2023
Quarter ended 31 Dec 2023: $65.0M, +23% on a year earlier; public on 1 Mar 2024
Quarter ended 31 Mar 2024: $51.3M, +25% on a year earlier; public on 9 May 2024
Quarter ended 30 Jun 2024: $52.7M, +15% on a year earlier; public on 2 Aug 2024
Quarter ended 30 Sep 2024: $57.9M, +27% on a year earlier; public on 8 Nov 2024
Quarter ended 31 Dec 2024: $75.4M, +16% on a year earlier; public on 28 Feb 2025
Quarter ended 31 Mar 2025: $52.6M, +2.6% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $63.2M, +20% on a year earlier; public on 1 Aug 2025
Quarter ended 30 Sep 2025: $67.5M, +17% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Dec 2025: $92.9M, +23% on a year earlier; public on 27 Feb 2026
Quarter ended 31 Mar 2026: $68.4M, +30% on a year earlier; public on 8 May 2026
Quarter ended 30 Jun 2026: $77.5M, +22% on a year earlier; public on 31 Jul 2026
Quarter ended 30 Sep 2026: $85.4M, +26% on a year earlier; public on 6 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $991K, -7.4% on a year earlier; public on 25 Feb 2022
Quarter ended 31 Mar 2022: $3.1M, +31% on a year earlier; public on 5 May 2022
Quarter ended 30 Jun 2022: $2.0M, -6.5% on a year earlier; public on 4 Aug 2022
Quarter ended 30 Sep 2022: $1.4M, -43% on a year earlier; public on 10 Nov 2022
Quarter ended 31 Dec 2022: $1.1M, +14% on a year earlier; public on 24 Feb 2023
Quarter ended 31 Mar 2023: $1.4M, -54% on a year earlier; public on 11 May 2023
Quarter ended 30 Jun 2023: $4.2M, +112% on a year earlier; public on 3 Aug 2023
Quarter ended 30 Sep 2023: $6.6M, +366% on a year earlier; public on 9 Nov 2023
Quarter ended 31 Dec 2023: $7.8M, +596% on a year earlier; public on 1 Mar 2024
Quarter ended 31 Mar 2024: $14.0M, +892% on a year earlier; public on 9 May 2024
Quarter ended 30 Jun 2024: $16.8M, +299% on a year earlier; public on 2 Aug 2024
Quarter ended 30 Sep 2024: $19.4M, +195% on a year earlier; public on 8 Nov 2024
Quarter ended 31 Dec 2024: $13.8M, +76% on a year earlier; public on 28 Feb 2025
Quarter ended 31 Mar 2025: $14.2M, +1.4% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $8.1M, -51% on a year earlier; public on 1 Aug 2025
Quarter ended 30 Sep 2025: $2.6M, -86% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Dec 2025: $2.2M, -84% on a year earlier; public on 27 Feb 2026
Quarter ended 31 Mar 2026: $1.3M, -91% on a year earlier; public on 8 May 2026
Quarter ended 30 Jun 2026: $1.9M, -76% on a year earlier; public on 31 Jul 2026
Quarter ended 30 Sep 2026: $2.0M, -22% on a year earlier; public on 6 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 166; public on 14 Feb 2022
31 Mar 2022 report: 188; public on 16 May 2022
30 Jun 2022 report: 172; public on 15 Aug 2022
30 Sep 2022 report: 165; public on 14 Nov 2022
31 Dec 2022 report: 166; public on 14 Feb 2023
31 Mar 2023 report: 190; public on 15 May 2023
30 Jun 2023 report: 184; public on 14 Aug 2023
30 Sep 2023 report: 197; public on 14 Nov 2023
31 Dec 2023 report: 213; public on 14 Feb 2024
31 Mar 2024 report: 241; public on 15 May 2024
30 Jun 2024 report: 241; public on 14 Aug 2024
30 Sep 2024 report: 254; public on 14 Nov 2024
31 Dec 2024 report: 269; public on 14 Feb 2025
31 Mar 2025 report: 264; public on 15 May 2025
30 Jun 2025 report: 258; public on 14 Aug 2025
30 Sep 2025 report: 238; public on 14 Nov 2025
31 Dec 2025 report: 264; public on 17 Feb 2026
31 Mar 2026 report: 273; public on 15 May 2026
30 Jun 2026 report: 317; public on 14 Aug 2026
30 Sep 2026 report: 319; public on 16 Nov 2026
Federal obligations
Month from 1 Dec 2021: $138K published
Month from 1 Jan 2022: $63K published
Month from 1 Feb 2022: $49K published
Month from 1 Mar 2022: $111K published
Month from 1 Apr 2022: $49K published
Month from 1 Jul 2022: $97K published
Month from 1 Sep 2022: $46K published
Month from 1 Oct 2022: $49K published
Month from 1 Nov 2022: $49K published
Month from 1 Jan 2023: $52K published
Month from 1 Feb 2023: $52K published
Month from 1 Mar 2023: $52K published
Month from 1 Apr 2023: -$101K published
Month from 1 May 2023: $52K published
Month from 1 Jun 2023: $52K published
Month from 1 Oct 2023: $52K published
Month from 1 Dec 2023: $52K published
Month from 1 Mar 2024: $56K published
Month from 1 Apr 2024: $56K published
Month from 1 May 2024: $56K published
Month from 1 Aug 2024: $56K published
Month from 1 Sep 2024: $112K published
Month from 1 Oct 2024: $56K published
Month from 1 Dec 2024: $56K published
Month from 1 Jan 2025: $117K published
Month from 1 Feb 2025: $61K published
Month from 1 Aug 2025: $61K published
Month from 1 Jan 2026: $70K published
Month from 1 Mar 2026: $70K published
Month from 1 Apr 2026: $35.0M published
Month from 1 May 2026: $70K published
Month from 1 Jul 2026: $153K published
Month from 1 Sep 2026: $76K published
Month from 1 Oct 2026: $153K published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is 13F holders (funds reporting the stock) at 319 (30 Sep 2026), 1.2× its normal reading; higher than 100% of its own history.
  • Insider net buying (open market): Insiders sold a net $13.1M in the last 12 months (the 12 months before: -$11.6M).
  • Revenue per quarter: Revenue $85.4M in the latest quarter, +26% on a year earlier.
  • Capital spending per quarter: Capital spending $2.0M in the latest quarter, -22% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Last 90 days: 8 sales, $5.9M; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
17 Nov 2026Jonathan SiegalPrincipal Accounting OfficerSellafter exercising options1,885$57.71$109KForm 4
12 Nov 2026Joseph Anthony Mara JrChief Financial OfficerSellplanned in advance (10b5-1); after exercising options25,008$58.26$1.5MForm 4
12 Nov 2026Kevin F McLaughlinDirectorSellplanned in advance (10b5-1); after exercising options7,000$58.96$413KForm 4
12 Nov 2026Robert L Zerbe MdDirectorSellplanned in advance (10b5-1); after exercising options2,000$57.88$116KForm 4
9 Nov 2026Joseph Anthony Mara JrChief Financial OfficerSellplanned in advance (10b5-1); after exercising options50,000$53.48$2.7MForm 4
6 Nov 2026Jonathan SiegalPrincipal Accounting OfficerSellplanned in advance (10b5-1); after exercising options1,500$52.90$79KForm 4
6 Nov 2026Sean C. FlynnChief Legal OfficerSellplanned in advance (10b5-1); after exercising options15,000$51.92$779KForm 4
6 Nov 2026Robert L Zerbe MdDirectorSellplanned in advance (10b5-1); after exercising options5,500$49.12$270KForm 4

319 institutions reported shares at the end of Q3 2026, 100% of the shares outstanding; 36 opened a position, 37 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.8.2M16.0%$327.8M+75K+0.9%
State Street Corp3.2M6.28%$128.6M-91K-2.8%
Congress Asset Management Co2.6M5.00%$102.4M-364K-12%
Vanguard Capital Management LLC2.3M4.43%$90.7M+4,573+0.2%
William Blair Investment Management, LLC2.0M3.84%$78.7M-32K-1.6%
BNP PARIBAS ASSET MANAGEMENT Holding S.A.1.6M3.21%$65.8M+2290%
Conestoga Capital Advisors, LLC1.6M3.08%$63.1M-511K-25%
Soleus Capital Management, L.P.1.6M3.05%$62.4M+95K+6.5%
GW&K Investment Management, LLC1.5M3.01%-12K-0.8%
Geode Capital Management, LLC1.4M2.74%$56.2M+59K+4.4%

Federal contracts

All 1 federal contracts

1 new award in 12 months, $34.9M obligated when signed. New awards only; later changes to an award are not listed.

SignedAgencyAmountWhat forSource
1 Apr 2026Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and Response$34.9Mup to $191.8MNON SURGICAL DEBRIDEMENTUSAspending

Company events

All 38 company events

Nothing in 12 months; the latest was filed 2 May 2025. Results releases and routine reports are left out.

FiledWhat happenedSource
2 May 2025Director or officer changeSame filing: shareholder vote results8-K
5 May 2023Director or officer changeSame filing: shareholder vote results8-K
2 Aug 2022Signed a major agreementSame filing: took on new debt8-K
29 Apr 2022Director or officer changeSame filing: shareholder vote results8-K
24 Feb 2022Director or officer change8-K
2 Feb 2022Signed a major agreementSame filing: took on new debt8-K
27 Aug 2021Signed a major agreement8-K
21 Jun 2021Director or officer change8-K

24 open postings; careers site tracked since 21 Nov 2026. Most in Legal, policy & compliance 8%, Manufacturing & production 8%, Marketing & communications 8%, Customer success & support 4%.

PostedJobLocation
20 Nov 2026Territory Development Representative - Chicago, ILChicago, IL, US
20 Nov 2026Territory Development Representative - Denver, CODenver, CO, US
20 Nov 2026Territory Development Representative - Dallas, TXDallas, TX, US
20 Nov 2026Territory Development Representative - Tampa/Orlando, FLTampa, FL, US; Orlando, FL, US
20 Nov 2026Territory Development Representative - Greenbay/Milwaukee, WINot stated
19 Nov 2026Business Development DirectorSales & business developmentUS
19 Nov 2026Digital Marketing Operations SpecialistMarketing & communicationsBurlington, MA, US
18 Nov 2026Joint Restoration Territory ManagerSt. Louis, MO, US

The 5 newest of 50 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

21 May 2024confirmed

Confirmed across sources Institutional holdings and Filings + Financials

Vericel (VCEL): spent $14.0M on capital projects in the quarter ended 31 Mar 2024, 9.9× the same quarter last year, while it saw 41 13F filers open a new position in the quarter ended 31 Mar 2024, 1.1× the same quarter last year. Two unrelated kinds of activity within 7 days.

  • Financials: Quarterly capital spending jump, became public on 14 May 2024
  • Institutional holdings: Many funds opening a new position, became public on 15 May 2024
2022-03-31: $3.1M2022-06-30: $2.0M2022-09-30: $1.4M2022-12-31: $1.1M2023-03-31: $1.4M2023-06-30: $4.2M2023-09-30: $6.6M2023-12-31: $7.8M2024-03-31: $14.0M
The quarter ended 31 Mar 2024 against the 8 quarters before it. this quarterearliernormal: $2.5M
See the evidence (2 changes)

Financials: Quarterly capital spending jump became public on 14 May 2024

Vericel spent $14.0M on capital projects in the quarter ended 31 Mar 2024, 9.9× the same quarter last year.

This period
$14.0M (the quarter ended 31 Mar 2024)
Normal quarter (median of 8 earlier)
$2.5M
Typical spread (median absolute deviation)
$1.3M
How far from its usual level
+6.1
Same quarter last year
$1.4M
History used
4,931 days
2022-03-31: $3.1M2022-06-30: $2.0M2022-09-30: $1.4M2022-12-31: $1.1M2023-03-31: $1.4M2023-06-30: $4.2M2023-09-30: $6.6M2023-12-31: $7.8M2024-03-31: $14.0M
the quarter ended 31 Mar 20248 earlier quartersnormal: $2.5M

Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

Check it at the source: SEC EDGAR quarterly reports.

Institutional holdings: Many funds opening a new position became public on 15 May 2024

Vericel saw 41 13F filers open a new position in the quarter ended 31 Mar 2024, 1.1× the same quarter last year.

This period
41 (the quarter ended 31 Mar 2024)
Normal quarter (median of 8 earlier)
23.5
Typical spread (median absolute deviation)
2.5
How far from its usual level
+4.7
Same quarter last year
36
History used
3,378 days
2022-03-31: 262022-06-30: 172022-09-30: 212022-12-31: 212023-03-31: 362023-06-30: 232023-09-30: 242023-12-31: 252024-03-31: 41
the quarter ended 31 Mar 20248 earlier quartersnormal: 23.5

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 13 Apr 2026Government contracts change

    booked $35.0M in federal contract and grant obligations in April 2026, against none in the same month last year.

    See the evidence
    This period
    $35.0M (April 2026)
    Normal month (median of 5 earlier)
    $0
    Typical spread (median absolute deviation)
    $0
    How far from its usual level
    +35.0
    Same month last year
    $0
    History used
    2,033 days
    2021-04-01: $02022-04-01: $49K2023-04-01: $02024-04-01: $02025-04-01: $02026-04-01: $35.0M
    April 20265 earlier monthsnormal: $0

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.

    Check it at the source: USAspending.gov award search.

  2. 7 Apr 2026Government contracts change

    won its first federal award in our data, a $34.9M Department of Health and Human Services contract.

    See the evidence (1 source record)
    Source coverage starts
    7 Oct 2007
    Earlier events of other kinds
    0

    "First" means first in our data: it fires only when the source's history began at least 365 days earlier.

  3. 7 Apr 2026Government contracts record

    VERICEL CORPORATION: new Department of Health and Human Services contract 75A50126C00002 ($34.9M) (dated 1 Apr 2026)

  4. 17 Feb 2026Institutional holdings change

    saw 43 13F filers open a new position in the quarter ended 31 Dec 2025, 1.3× the same quarter last year.

    Same quarter last year: 34; its normal quarter is 27.5.

    See the evidence
    This period
    43 (the quarter ended 31 Dec 2025)
    Normal quarter (median of 8 earlier)
    27.5
    Typical spread (median absolute deviation)
    2
    How far from its usual level
    +5.2
    Same quarter last year
    34
    History used
    4,018 days
    2023-12-31: 252024-03-31: 412024-06-30: 282024-09-30: 252024-12-31: 342025-03-31: 272025-06-30: 292025-09-30: 262025-12-31: 43
    the quarter ended 31 Dec 20258 earlier quartersnormal: 27.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  5. 27 Aug 2025Short interest and volume change

    had 5.6M shares sold short in the 15 Aug 2025 report, 1.8× the same report last year.

    Same report last year: 3.1M; its normal report is 3.9M.

    See the evidence
    This period
    5.6M (the 15 Aug 2025 report)
    Normal report (median of 24 earlier)
    3.9M
    Typical spread (median absolute deviation)
    316K
    How far from its usual level
    +3.8
    Same report last year
    3.1M
    History used
    2,786 days
    2024-08-15: 3.1M2024-08-30: 3.4M2024-09-13: 3.6M2024-09-30: 3.5M2024-10-15: 3.8M2024-10-31: 4.2M2024-11-15: 3.7M2024-11-29: 4.0M2024-12-13: 3.7M2024-12-31: 3.7M2025-01-15: 3.7M2025-01-31: 3.8M2025-02-14: 3.6M2025-02-28: 3.9M2025-03-14: 3.5M2025-03-31: 4.0M2025-04-15: 4.5M2025-04-30: 4.6M2025-05-15: 4.2M2025-05-30: 4.6M2025-06-13: 4.6M2025-06-30: 4.9M2025-07-15: 5.3M2025-07-31: 5.6M2025-08-15: 5.6M
    the 15 Aug 2025 report24 earlier reportsnormal: 3.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  6. 12 Aug 2025Short interest and volume change

    had 5.6M shares sold short in the 31 Jul 2025 report, 1.9× the same report last year.

    Same report last year: 3.0M; its normal report is 3.8M.

    See the evidence
    This period
    5.6M (the 31 Jul 2025 report)
    Normal report (median of 24 earlier)
    3.8M
    Typical spread (median absolute deviation)
    254K
    How far from its usual level
    +4.6
    Same report last year
    3.0M
    History used
    2,771 days
    2024-07-31: 3.0M2024-08-15: 3.1M2024-08-30: 3.4M2024-09-13: 3.6M2024-09-30: 3.5M2024-10-15: 3.8M2024-10-31: 4.2M2024-11-15: 3.7M2024-11-29: 4.0M2024-12-13: 3.7M2024-12-31: 3.7M2025-01-15: 3.7M2025-01-31: 3.8M2025-02-14: 3.6M2025-02-28: 3.9M2025-03-14: 3.5M2025-03-31: 4.0M2025-04-15: 4.5M2025-04-30: 4.6M2025-05-15: 4.2M2025-05-30: 4.6M2025-06-13: 4.6M2025-06-30: 4.9M2025-07-15: 5.3M2025-07-31: 5.6M
    the 31 Jul 2025 report24 earlier reportsnormal: 3.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  7. 25 Jul 2025Short interest and volume change

    had 5.3M shares sold short in the 15 Jul 2025 report, 2.0× the same report last year.

    Same report last year: 2.7M; its normal report is 3.7M.

    See the evidence
    This period
    5.3M (the 15 Jul 2025 report)
    Normal report (median of 24 earlier)
    3.7M
    Typical spread (median absolute deviation)
    262K
    How far from its usual level
    +4.2
    Same report last year
    2.7M
    History used
    2,755 days
    2024-07-15: 2.7M2024-07-31: 3.0M2024-08-15: 3.1M2024-08-30: 3.4M2024-09-13: 3.6M2024-09-30: 3.5M2024-10-15: 3.8M2024-10-31: 4.2M2024-11-15: 3.7M2024-11-29: 4.0M2024-12-13: 3.7M2024-12-31: 3.7M2025-01-15: 3.7M2025-01-31: 3.8M2025-02-14: 3.6M2025-02-28: 3.9M2025-03-14: 3.5M2025-03-31: 4.0M2025-04-15: 4.5M2025-04-30: 4.6M2025-05-15: 4.2M2025-05-30: 4.6M2025-06-13: 4.6M2025-06-30: 4.9M2025-07-15: 5.3M
    the 15 Jul 2025 report24 earlier reportsnormal: 3.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  8. 2 May 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  9. 2 May 2025Filings record

    Director or officer change

  10. 6 Aug 2024Financials change

    spent $16.8M on capital projects in the quarter ended 30 Jun 2024, 4.0× the same quarter last year.

    Same quarter last year: $4.2M; its normal quarter is $3.1M.

    See the evidence
    This period
    $16.8M (the quarter ended 30 Jun 2024)
    Normal quarter (median of 8 earlier)
    $3.1M
    Typical spread (median absolute deviation)
    $1.8M
    How far from its usual level
    +5.1
    Same quarter last year
    $4.2M
    History used
    5,022 days
    2022-06-30: $2.0M2022-09-30: $1.4M2022-12-31: $1.1M2023-03-31: $1.4M2023-06-30: $4.2M2023-09-30: $6.6M2023-12-31: $7.8M2024-03-31: $14.0M2024-06-30: $16.8M
    the quarter ended 30 Jun 20248 earlier quartersnormal: $3.1M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  11. 21 May 2024several at once

    spent $14.0M on capital projects in the quarter ended 31 Mar 2024, 9.9× the same quarter last year, while it saw 41 13F filers open a new position in the quarter ended 31 Mar 2024, 1.1× the same quarter last year. Two unrelated kinds of activity within 7 days.

    See the evidence (2 changes)

    Financials: Quarterly capital spending jump became public on 14 May 2024

    Vericel spent $14.0M on capital projects in the quarter ended 31 Mar 2024, 9.9× the same quarter last year.

    This period
    $14.0M (the quarter ended 31 Mar 2024)
    Normal quarter (median of 8 earlier)
    $2.5M
    Typical spread (median absolute deviation)
    $1.3M
    How far from its usual level
    +6.1
    Same quarter last year
    $1.4M
    History used
    4,931 days
    2022-03-31: $3.1M2022-06-30: $2.0M2022-09-30: $1.4M2022-12-31: $1.1M2023-03-31: $1.4M2023-06-30: $4.2M2023-09-30: $6.6M2023-12-31: $7.8M2024-03-31: $14.0M
    the quarter ended 31 Mar 20248 earlier quartersnormal: $2.5M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

    Institutional holdings: Many funds opening a new position became public on 15 May 2024

    Vericel saw 41 13F filers open a new position in the quarter ended 31 Mar 2024, 1.1× the same quarter last year.

    This period
    41 (the quarter ended 31 Mar 2024)
    Normal quarter (median of 8 earlier)
    23.5
    Typical spread (median absolute deviation)
    2.5
    How far from its usual level
    +4.7
    Same quarter last year
    36
    History used
    3,378 days
    2022-03-31: 262022-06-30: 172022-09-30: 212022-12-31: 212023-03-31: 362023-06-30: 232023-09-30: 242023-12-31: 252024-03-31: 41
    the quarter ended 31 Mar 20248 earlier quartersnormal: 23.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  12. 15 May 2024Institutional holdings change

    saw 41 13F filers open a new position in the quarter ended 31 Mar 2024, 1.1× the same quarter last year.

    Same quarter last year: 36; its normal quarter is 23.5.

    See the evidence
    This period
    41 (the quarter ended 31 Mar 2024)
    Normal quarter (median of 8 earlier)
    23.5
    Typical spread (median absolute deviation)
    2.5
    How far from its usual level
    +4.7
    Same quarter last year
    36
    History used
    3,378 days
    2022-03-31: 262022-06-30: 172022-09-30: 212022-12-31: 212023-03-31: 362023-06-30: 232023-09-30: 242023-12-31: 252024-03-31: 41
    the quarter ended 31 Mar 20248 earlier quartersnormal: 23.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  13. 14 May 2024Financials change

    spent $14.0M on capital projects in the quarter ended 31 Mar 2024, 9.9× the same quarter last year.

    Same quarter last year: $1.4M; its normal quarter is $2.5M.

    See the evidence
    This period
    $14.0M (the quarter ended 31 Mar 2024)
    Normal quarter (median of 8 earlier)
    $2.5M
    Typical spread (median absolute deviation)
    $1.3M
    How far from its usual level
    +6.1
    Same quarter last year
    $1.4M
    History used
    4,931 days
    2022-03-31: $3.1M2022-06-30: $2.0M2022-09-30: $1.4M2022-12-31: $1.1M2023-03-31: $1.4M2023-06-30: $4.2M2023-09-30: $6.6M2023-12-31: $7.8M2024-03-31: $14.0M
    the quarter ended 31 Mar 20248 earlier quartersnormal: $2.5M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  14. 5 Mar 2024Financials change

    spent $7.8M on capital projects in the quarter ended 31 Dec 2023, 7.0× the same quarter last year.

    Same quarter last year: $1.1M; its normal quarter is $1.7M.

    See the evidence
    This period
    $7.8M (the quarter ended 31 Dec 2023)
    Normal quarter (median of 8 earlier)
    $1.7M
    Typical spread (median absolute deviation)
    $639K
    How far from its usual level
    +6.1
    Same quarter last year
    $1.1M
    History used
    4,840 days
    2021-12-31: $991K2022-03-31: $3.1M2022-06-30: $2.0M2022-09-30: $1.4M2022-12-31: $1.1M2023-03-31: $1.4M2023-06-30: $4.2M2023-09-30: $6.6M2023-12-31: $7.8M
    the quarter ended 31 Dec 20238 earlier quartersnormal: $1.7M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  15. 14 Nov 2023Financials change

    spent $6.6M on capital projects in the quarter ended 30 Sep 2023, 4.7× the same quarter last year.

    Same quarter last year: $1.4M; its normal quarter is $1.7M.

    See the evidence
    This period
    $6.6M (the quarter ended 30 Sep 2023)
    Normal quarter (median of 8 earlier)
    $1.7M
    Typical spread (median absolute deviation)
    $639K
    How far from its usual level
    +4.9
    Same quarter last year
    $1.4M
    History used
    4,748 days
    2021-09-30: $2.5M2021-12-31: $991K2022-03-31: $3.1M2022-06-30: $2.0M2022-09-30: $1.4M2022-12-31: $1.1M2023-03-31: $1.4M2023-06-30: $4.2M2023-09-30: $6.6M
    the quarter ended 30 Sep 20238 earlier quartersnormal: $1.7M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  16. 5 May 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  17. 5 May 2023Filings record

    Director or officer change

  18. 11 May 2022Short interest and volume change

    had 8.2M shares sold short in the 29 Apr 2022 report, 2.4× the same report last year.

    Same report last year: 3.4M; its normal report is 4.3M.

    See the evidence
    This period
    8.2M (the 29 Apr 2022 report)
    Normal report (median of 24 earlier)
    4.3M
    Typical spread (median absolute deviation)
    672K
    How far from its usual level
    +3.8
    Same report last year
    3.4M
    History used
    1,582 days
    2021-04-15: 3.8M2021-04-30: 3.4M2021-05-14: 3.6M2021-05-28: 3.9M2021-06-15: 4.0M2021-06-30: 3.7M2021-07-15: 3.4M2021-07-30: 3.6M2021-08-13: 3.7M2021-08-31: 3.9M2021-09-15: 4.0M2021-09-30: 4.7M2021-10-15: 4.2M2021-10-29: 4.5M2021-11-15: 4.5M2021-11-30: 4.9M2021-12-15: 5.1M2022-01-14: 7.0M2022-01-31: 7.0M2022-02-15: 6.8M2022-02-28: 6.7M2022-03-15: 7.9M2022-03-31: 7.9M2022-04-14: 8.6M2022-04-29: 8.2M
    the 29 Apr 2022 report24 earlier reportsnormal: 4.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  19. 29 Apr 2022Filings record

    Director or officer change

  20. 27 Apr 2022Short interest and volume change

    had 8.6M shares sold short in the 14 Apr 2022 report, 2.2× the same report last year.

    Same report last year: 3.8M; its normal report is 4.3M.

    See the evidence
    This period
    8.6M (the 14 Apr 2022 report)
    Normal report (median of 24 earlier)
    4.3M
    Typical spread (median absolute deviation)
    636K
    How far from its usual level
    +4.5
    Same report last year
    3.8M
    History used
    1,567 days
    2021-03-31: 4.9M2021-04-15: 3.8M2021-04-30: 3.4M2021-05-14: 3.6M2021-05-28: 3.9M2021-06-15: 4.0M2021-06-30: 3.7M2021-07-15: 3.4M2021-07-30: 3.6M2021-08-13: 3.7M2021-08-31: 3.9M2021-09-15: 4.0M2021-09-30: 4.7M2021-10-15: 4.2M2021-10-29: 4.5M2021-11-15: 4.5M2021-11-30: 4.9M2021-12-15: 5.1M2022-01-14: 7.0M2022-01-31: 7.0M2022-02-15: 6.8M2022-02-28: 6.7M2022-03-15: 7.9M2022-03-31: 7.9M2022-04-14: 8.6M
    the 14 Apr 2022 report24 earlier reportsnormal: 4.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  21. 12 Apr 2022Short interest and volume change

    had 7.9M shares sold short in the 31 Mar 2022 report, 1.6× the same report last year.

    Same report last year: 4.9M; its normal report is 4.1M.

    See the evidence
    This period
    7.9M (the 31 Mar 2022 report)
    Normal report (median of 24 earlier)
    4.1M
    Typical spread (median absolute deviation)
    526K
    How far from its usual level
    +4.9
    Same report last year
    4.9M
    History used
    1,553 days
    2021-03-15: 3.0M2021-03-31: 4.9M2021-04-15: 3.8M2021-04-30: 3.4M2021-05-14: 3.6M2021-05-28: 3.9M2021-06-15: 4.0M2021-06-30: 3.7M2021-07-15: 3.4M2021-07-30: 3.6M2021-08-13: 3.7M2021-08-31: 3.9M2021-09-15: 4.0M2021-09-30: 4.7M2021-10-15: 4.2M2021-10-29: 4.5M2021-11-15: 4.5M2021-11-30: 4.9M2021-12-15: 5.1M2022-01-14: 7.0M2022-01-31: 7.0M2022-02-15: 6.8M2022-02-28: 6.7M2022-03-15: 7.9M2022-03-31: 7.9M
    the 31 Mar 2022 report24 earlier reportsnormal: 4.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  22. 25 Mar 2022Short interest and volume change

    had 7.9M shares sold short in the 15 Mar 2022 report, 2.6× the same report last year.

    Same report last year: 3.0M; its normal report is 4.0M.

    See the evidence
    This period
    7.9M (the 15 Mar 2022 report)
    Normal report (median of 24 earlier)
    4.0M
    Typical spread (median absolute deviation)
    551K
    How far from its usual level
    +4.8
    Same report last year
    3.0M
    History used
    1,537 days
    2021-02-26: 3.3M2021-03-15: 3.0M2021-03-31: 4.9M2021-04-15: 3.8M2021-04-30: 3.4M2021-05-14: 3.6M2021-05-28: 3.9M2021-06-15: 4.0M2021-06-30: 3.7M2021-07-15: 3.4M2021-07-30: 3.6M2021-08-13: 3.7M2021-08-31: 3.9M2021-09-15: 4.0M2021-09-30: 4.7M2021-10-15: 4.2M2021-10-29: 4.5M2021-11-15: 4.5M2021-11-30: 4.9M2021-12-15: 5.1M2022-01-14: 7.0M2022-01-31: 7.0M2022-02-15: 6.8M2022-02-28: 6.7M2022-03-15: 7.9M
    the 15 Mar 2022 report24 earlier reportsnormal: 4.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  23. 26 Feb 2022Short interest and volume change

    had 6.8M shares sold short in the 15 Feb 2022 report, 2.1× the same report last year.

    Same report last year: 3.3M; its normal report is 3.9M.

    See the evidence
    This period
    6.8M (the 15 Feb 2022 report)
    Normal report (median of 24 earlier)
    3.9M
    Typical spread (median absolute deviation)
    534K
    How far from its usual level
    +3.7
    Same report last year
    3.3M
    History used
    1,509 days
    2021-01-29: 3.6M2021-02-12: 3.3M2021-02-26: 3.3M2021-03-15: 3.0M2021-03-31: 4.9M2021-04-15: 3.8M2021-04-30: 3.4M2021-05-14: 3.6M2021-05-28: 3.9M2021-06-15: 4.0M2021-06-30: 3.7M2021-07-15: 3.4M2021-07-30: 3.6M2021-08-13: 3.7M2021-08-31: 3.9M2021-09-15: 4.0M2021-09-30: 4.7M2021-10-15: 4.2M2021-10-29: 4.5M2021-11-15: 4.5M2021-11-30: 4.9M2021-12-15: 5.1M2022-01-14: 7.0M2022-01-31: 7.0M2022-02-15: 6.8M
    the 15 Feb 2022 report24 earlier reportsnormal: 3.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  24. 24 Feb 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  25. 24 Feb 2022Filings record

    Director or officer change

  26. 10 Feb 2022Short interest and volume change

    had 7.0M shares sold short in the 31 Jan 2022 report, 1.9× the same report last year.

    Same report last year: 3.6M; its normal report is 3.9M.

    See the evidence
    This period
    7.0M (the 31 Jan 2022 report)
    Normal report (median of 24 earlier)
    3.9M
    Typical spread (median absolute deviation)
    438K
    How far from its usual level
    +4.8
    Same report last year
    3.6M
    History used
    1,494 days
    2021-01-15: 3.5M2021-01-29: 3.6M2021-02-12: 3.3M2021-02-26: 3.3M2021-03-15: 3.0M2021-03-31: 4.9M2021-04-15: 3.8M2021-04-30: 3.4M2021-05-14: 3.6M2021-05-28: 3.9M2021-06-15: 4.0M2021-06-30: 3.7M2021-07-15: 3.4M2021-07-30: 3.6M2021-08-13: 3.7M2021-08-31: 3.9M2021-09-15: 4.0M2021-09-30: 4.7M2021-10-15: 4.2M2021-10-29: 4.5M2021-11-15: 4.5M2021-11-30: 4.9M2021-12-15: 5.1M2022-01-14: 7.0M2022-01-31: 7.0M
    the 31 Jan 2022 report24 earlier reportsnormal: 3.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  27. 27 Jan 2022Short interest and volume change

    had 7.0M shares sold short in the 14 Jan 2022 report, 2.0× the same report last year.

    Same report last year: 3.5M; its normal report is 3.8M.

    See the evidence
    This period
    7.0M (the 14 Jan 2022 report)
    Normal report (median of 24 earlier)
    3.8M
    Typical spread (median absolute deviation)
    332K
    How far from its usual level
    +6.6
    Same report last year
    3.5M
    History used
    1,477 days
    2020-12-31: 3.6M2021-01-15: 3.5M2021-01-29: 3.6M2021-02-12: 3.3M2021-02-26: 3.3M2021-03-15: 3.0M2021-03-31: 4.9M2021-04-15: 3.8M2021-04-30: 3.4M2021-05-14: 3.6M2021-05-28: 3.9M2021-06-15: 4.0M2021-06-30: 3.7M2021-07-15: 3.4M2021-07-30: 3.6M2021-08-13: 3.7M2021-08-31: 3.9M2021-09-15: 4.0M2021-09-30: 4.7M2021-10-15: 4.2M2021-10-29: 4.5M2021-11-15: 4.5M2021-11-30: 4.9M2021-12-15: 5.1M2022-01-14: 7.0M
    the 14 Jan 2022 report24 earlier reportsnormal: 3.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  28. 21 Jun 2021Filings record

    Director or officer change

  29. 2 Jun 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  30. 2 Jun 2021Filings record

    Director or officer change

  31. 17 May 2021Institutional holdings change

    saw 58 13F filers open a new position in the quarter ended 31 Mar 2021, 3.2× the same quarter last year.

    Same quarter last year: 18; its normal quarter is 23.

    See the evidence
    This period
    58 (the quarter ended 31 Mar 2021)
    Normal quarter (median of 8 earlier)
    23
    Typical spread (median absolute deviation)
    6.5
    How far from its usual level
    +3.6
    Same quarter last year
    18
    History used
    2,282 days
    2019-03-31: 332019-06-30: 142019-09-30: 152019-12-31: 252020-03-31: 182020-06-30: 252020-09-30: 212020-12-31: 352021-03-31: 58
    the quarter ended 31 Mar 20218 earlier quartersnormal: 23

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  32. 12 Feb 2021Filings record

    A major agreement ended

  33. 25 Jan 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  34. 25 Jan 2021Filings record

    Director or officer change

  35. 8 Sep 2020Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  36. 8 Sep 2020Filings record

    Director or officer change

  37. 1 May 2020Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  38. 1 May 2020Filings record

    Director or officer change

  39. 3 Jun 2019Filings record

    Director or officer change

  40. 14 May 2019Financials change

    reported revenue of $22K for the quarter ended 31 Mar 2019, 100% below the same quarter last year.

    Same quarter last year: $18.0M; its normal quarter is $18.5M.

    See the evidence
    This period
    $22K (the quarter ended 31 Mar 2019)
    Normal quarter (median of 8 earlier)
    $18.5M
    Typical spread (median absolute deviation)
    $4.1M
    How far from its usual level
    -3.0
    Same quarter last year
    $18.0M
    History used
    2,922 days
    2017-03-31: $9.4M2017-06-30: $17.0M2017-09-30: $14.3M2017-12-31: $23.4M2018-03-31: $18.0M2018-06-30: $19.0M2018-09-30: $22.5M2018-12-31: $31.3M2019-03-31: $22K
    the quarter ended 31 Mar 20198 earlier quartersnormal: $18.5M

    Fires when the period is at least 3.0 robust standard deviations away from the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

Showing the newest 40 of 49 entries; narrow the window or the kind of data to see older ones.

Not listed: 281 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0000887359
Ticker
VCEL
Domain
vcel.com
Hq location
MA|BURLINGTON|01803 (1 unverified)
Name
AASTROM BIOSCIENCES INC, Document, EX-21.1, ex211subsidiariesofregistr.htm and 4 more
Uei
WHK8B1525XA7
Wikipedia
Vericel
  • SEC Form 13F institutional holdings432 data points31 Dec 2014 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)146 records9 Mar 2016 to 5 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1097 data points30 Jun 2008 to 29 Oct 2026
  • SEC Form 4 insider transactions153 records, 508 data points29 Mar 2016 to 17 Nov 2026
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards1 record, 312 data points29 Sep 2015 to 30 Sep 2026
  • Wikipedia pageviews10 data points11 Nov 2026 to 20 Nov 2026